Boris M. Pfeiffer

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial

Yi‐Long Wu, Valentina Guarneri, Pei Jye Voon et al. · The Lancet Oncology · 2024 · 70 citations · Full text

Met Amplification, Medicine, Pathology +8

Series: Pragmatic trials and real world evidence: Paper 4. Informed consent

Shona Kalkman, Ghislaine J. M. W. van Thiel, Mira G. P. Zuidgeest et al. · Journal of Clinical Epidemiology · 2017 · 43 citations · Full text

Forensic Psychology, Drug Life Cycle, Clinical Decision-making +22

Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes

Sina Buck, Delia Waldenmaier, Christina Liebing et al. · Experimental and Clinical Endocrinology & Diabetes · 2021 · 17 citations

Impact of modified-release prednisone on functional ability in patients with rheumatoid arthritis

Boris M. Pfeiffer, Stefanie Krenzer, R. Dockhorn et al. · Rheumatology International · 2012 · 14 citations

Inflammation, Rheumatology, Modified-release Prednisone +12